Xcout Intel
Coultreon Biopharma competitors & alternatives
The 12 closest competitors and alternatives to Coultreon Biopharma among drug discovery companies — ranked by similarity to what Coultreon Biopharma actually does, not by market-cap band.
Subscribe to see Coultreon Biopharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Coultreon Biopharma
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
Coultreon Biopharma at a glance
Coultreon Biopharma is a drug discovery company headquartered in Belgium. It has raised at least $125M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Series A, raised $125M in April 2026. Xcout tracks 18 named people at Coultreon Biopharma, including Pierre Raboisson (Chief Executive Officer Chief Scientific Officer Co-founder).
Coultreon Biopharma leadership
- Pierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder
- Guy PeetersChief Financial Officer Co-founder
- Marie De VulderChief Legal Officer Co-founder
- Nate MassariChief Business Officer
- Prista CharuwornChief Medical Officer
- Pieter PeetersOperating & Technology Officer Co-founder
12 more named people on record for Coultreon Biopharma, with roles, board committees and tenure — see the full roster →
Coultreon Biopharma funding rounds
At least $125M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $125M | 10 named | |
| Seed | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Coultreon Biopharma competitors
Ranked by semantic similarity — how close each company is to Coultreon Biopharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
COUR Pharmaceuticals is a clinical-stage biotechnology company headquartered in Evanston, Illinois, founded in 2015. The firm focuses on reprogramming the immune system to develop novel treatments for autoimmune diseases.
Similar drug discovery company
NXI Therapeutics AG is a biotech company based in Basel, Switzerland, focused on researching and developing selective immunosuppressive drugs and immunotherapies for autoimmune diseases and transplantation.
Similar drug discovery company
Promise Bio is a biotechnology research startup transforming immune-mediated disease treatment with advanced precision therapies. Headquartered in Tel Aviv, Israel, the company emerged from stealth following a seed investment.
Similar drug discovery company
Baseimmune is a biotechnology research company headquartered in London, United Kingdom, pioneering active immunotherapies. The company combines cutting-edge computational design with advanced protein engineering to develop next-generation vaccines.
Similar drug discovery company
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Similar drug discovery company
Arkgen Bioscions is a South Korean immuno-oncology startup headquartered in Daejeon. The company recently raised a $6.67 million Series A funding round to advance its proprietary biotech research. It focuses on developing innovative biopharmaceutical treatments.
Similar drug discovery company
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Similar drug discovery company
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Similar drug discovery company
Immitra Bio GmbH is a biotechnology startup and ETH Zürich spin-off developing a scalable in-vivo genetic medicine platform to treat rare genetic diseases. Headquartered in Schlieren, Switzerland, the company secured early-stage venture funding to advance its gene-editing therapies.
Similar drug discovery company
Salvina Therapeutics AG is a Swiss biotechnology research company that develops novel antibodies targeting TNF and TNF superfamily members to address inflammatory and autoimmune diseases. The privately held firm focuses on drug development approaches designed to improve safety and overcome efficacy barriers in these therapeutic areas.
Similar drug discovery company
AllIn Bio is a drug discovery company headquartered in Woodside, California. The firm is developing a precision-immunology approach designed to treat the root cause of chronic inflammatory diseases.
Similar drug discovery company
META Pharmaceuticals Inc. is a pioneering biotechnology company focusing on immuno-metabolism and gastrointestinal therapeutics within immunology, operating research efforts connected to JLABS in Shanghai.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Coultreon Biopharma and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Coultreon Biopharmaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →